<body> <iframe src="http://www2.blogger.com/navbar.g?targetBlogID=6223270&amp;blogName=biotech+licensing%3A+James+Hatton&amp;publishMode=PUBLISH_MODE_FTP&amp;navbarType=BLUE&amp;layoutType=CLASSIC&amp;homepageUrl=http%3A%2F%2Fwww.jameshatton.com%2Fpublic%2Findex.html&amp;searchRoot=http%3A%2F%2Fblogsearch.google.com%2F" height="30px" width="100%" marginwidth="0" marginheight="0" scrolling="no" id="navbar-iframe" frameborder="0"></iframe> <div id="space-for-ie"></div>

Tuesday, March 06, 2007

Sources of Biotech Alliances for 2006

I monitor the public release of biotech collaboration agreements during the year, but I am sure I miss as many as I find. I keep a list of the ones that I think are interesting.

In preparing for a presentation last year at BPN 2006, in addition to my own watching, I used three sources of agreements to consider: Burrill and Company's quarterly reports, the Biotech CEO's conference, and the Scrip Awards.

This year, Burrill has not published the quarterly reports past April, 2006. I don't see anything posted about the Biotech CEO's conference.

That leaves the Scrip Awards. Here are the nominees for Best Partnership Alliance of the Year and for the Best Licensing Deal of the Year:




































The winner of the Best Partnership Alliance was: Atherogenics and AstraZeneca, and the Licensing Deal of the Year was Protherics and AstraZeneca.

Links to a growing list of the full text of the nominated agreements which have been publicly disclosed are posted to my agreement collection here: ScripAwards 2006 Agreements.

Update: Recombinant Capital has released its nominees for Breakthrough Alliance of 2006.

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home